Immunosuppressive Drugs: Azathioprine in the Treatment of Myasthenia Gravis
- 1 August 1987
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 505 (1) , 588-594
- https://doi.org/10.1111/j.1749-6632.1987.tb51327.x
Abstract
Click on the article title to read more.Keywords
This publication has 16 references indexed in Scilit:
- Myasthenia gravis: Reactivation of clinical disease and of automimmune factors after discontinuation of long‐term azathioprineAnnals of Neurology, 1985
- Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravisJournal of the Neurological Sciences, 1982
- Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities.Annals of the Rheumatic Diseases, 1982
- Letters to the EditorMuscle & Nerve, 1981
- Lack of oncogenicity with immunosuppressive therapyCancer, 1980
- Current Trends in the Management of Myasthenia Gravis: Plasmapheresis and Immunosuppressive TherapyAustralian and New Zealand Journal of Medicine, 1980
- PLASMA-EXCHANGE COMBINED WITH IMMUNOSUPPRESSIVE THERAPY IN MYASTHENIA GRAVISThe Lancet, 1979
- LONG-TERM EFFECTS OF REPEATED PLASMA EXCHANGE IN MYASTHENIA GRAVISThe Lancet, 1979
- Immunosuppressive Therapy in Rheumatic DiseaseMedical Clinics of North America, 1977
- RISK OF CANCER IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1973